A detailed history of Ingalls & Snyder LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ingalls & Snyder LLC holds 7,322 shares of LLY stock, worth $6.66 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
7,322
Previous 7,525 2.7%
Holding current value
$6.66 Million
Previous $5.85 Million 13.24%
% of portfolio
0.28%
Previous 0.26%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$724.87 - $909.04 $147,148 - $184,535
-203 Reduced 2.7%
7,322 $6.63 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $503,962 - $674,230
-851 Reduced 10.16%
7,525 $5.85 Million
Q4 2023

Jan 29, 2024

SELL
$525.19 - $619.13 $659,113 - $777,008
-1,255 Reduced 13.03%
8,376 $4.88 Million
Q3 2023

Nov 02, 2023

BUY
$434.7 - $599.3 $556,416 - $767,104
1,280 Added 15.33%
9,631 $5.17 Million
Q2 2023

Jul 27, 2023

SELL
$350.74 - $468.98 $1.16 Million - $1.55 Million
-3,303 Reduced 28.34%
8,351 $3.92 Million
Q1 2023

May 09, 2023

SELL
$310.63 - $364.82 $23,607 - $27,726
-76 Reduced 0.65%
11,654 $4 Million
Q4 2022

Jan 31, 2023

SELL
$321.55 - $374.67 $16,077 - $18,733
-50 Reduced 0.42%
11,730 $4.29 Million
Q3 2022

Oct 21, 2022

SELL
$296.48 - $337.87 $37,356 - $42,571
-126 Reduced 1.06%
11,780 $3.81 Million
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $32,053 - $37,636
115 Added 0.98%
11,906 $3.86 Million
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $687,172 - $853,980
-2,928 Reduced 19.89%
11,791 $3.38 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $102,306 - $126,963
-455 Reduced 3.0%
14,719 $4.07 Million
Q3 2021

Oct 27, 2021

SELL
$221.6 - $272.71 $49,860 - $61,359
-225 Reduced 1.46%
15,174 $3.51 Million
Q2 2021

Aug 03, 2021

SELL
$180.55 - $233.54 $22,568 - $29,192
-125 Reduced 0.81%
15,399 $3.53 Million
Q1 2021

Apr 21, 2021

SELL
$164.32 - $212.72 $100,728 - $130,397
-613 Reduced 3.8%
15,524 $2.9 Million
Q4 2020

Jan 27, 2021

BUY
$130.46 - $172.63 $54,010 - $71,468
414 Added 2.63%
16,137 $2.73 Million
Q3 2020

Oct 21, 2020

BUY
$146.22 - $169.13 $6,579 - $7,610
45 Added 0.29%
15,723 $2.33 Million
Q2 2020

Jul 31, 2020

SELL
$136.42 - $164.18 $66,163 - $79,627
-485 Reduced 3.0%
15,678 $2.57 Million
Q1 2020

Apr 22, 2020

SELL
$119.05 - $147.35 $126,669 - $156,780
-1,064 Reduced 6.18%
16,163 $2.24 Million
Q4 2019

Jan 15, 2020

BUY
$106.92 - $132.43 $136,323 - $168,848
1,275 Added 7.99%
17,227 $2.26 Million
Q2 2019

Jul 11, 2019

BUY
$110.79 - $129.32 $94,171 - $109,922
850 Added 5.63%
15,952 $1.77 Million
Q1 2019

Apr 11, 2019

SELL
$111.31 - $131.02 $5,565 - $6,551
-50 Reduced 0.33%
15,102 $1.96 Million
Q4 2018

Jan 24, 2019

SELL
$105.9 - $118.64 $344,175 - $385,580
-3,250 Reduced 17.66%
15,152 $1.75 Million
Q1 2018

Apr 17, 2018

SELL
$74.21 - $87.6 $21,520 - $25,404
-290 Reduced 1.55%
18,402 $1.42 Million
Q4 2017

Jan 19, 2018

BUY
$81.94 - $87.89 $5,735 - $6,152
70 Added 0.38%
18,692 $1.58 Million
Q3 2017

Oct 20, 2017

BUY
$77.07 - $85.54 $1.44 Million - $1.59 Million
18,622
18,622 $1.59 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.